The crocodile peptide market is currently in its infancy, with a number of competitors vying to get the crocodile peptide approved by the FDA (Food and Drug Administration). Although research into the antibiotic and other medicinal properties of crocodiles is not new, given the rise of drug-resistant bacteria and viruses and their decreasing effectiveness, crocodile peptide market appears to be gaining traction.
According to the WHO (World Health Organization), cancer is responsible for nearly one out of every six deaths worldwide, making it one of the most common diseases in modern times. While there are numerous medications available to treat the disease, many of them have unpleasant side effects, and others may become ineffective due to drug resistance. Scientists and researchers are working to bring crocodile peptides to market as a result of this factor.
Key Players in the Crocodile Peptide Market
Major pharmaceutical companies in America are now working hard to produce crocodile peptides using crocodile blood and oils, according to crocodile researcher Grahame Webb, though it’s difficult to justify which companies are working on crocodile peptides for commercial reasons. Leading industry players are collaborating on antimicrobial peptide research.
For example, Symcel and Colzyx collaborated to research antimicrobial peptides and their ability to reduce bacterial production. Nuritas, a recently founded company, uses artificial intelligence and DNA analysis to identify animal peptides that can help with a health-related cause.
Crocodile Peptide Market: Segmentation
The global crocodile peptide market can be segmented on the basis of peptide type, synthesis and end use.
On the basis of peptide type, the crocodile peptide market can be segmented into:
- Anionic Peptides
- Cationic Peptides
- Linear Cationic
On the basis of synthesis, the crocodile peptide market can be segmented into:
- Solid Phase
- Liquid Phase
- Hybrid Phase
On the basis of end use, the crocodile peptide market can be segmented into:
- Pharmaceutical & Biotechnology Companies
- Contract Development Organizations (CRO)
- Academic and Research Institutes
The market for crocodile peptides in North America is primarily driven by an increase in research. On the antibacterial peptide market for animals, Asia Pacific is the most developed region. The rise in spending on animal health care is a major driver of market expansion.
Increasing resistance to conventional antibiotics is expected to drive the market for animal antibacterial peptides, including crocodile peptides, during the forecast period. Furthermore, the increased use of antibiotics in animal feed for the treatment of various infections and diseases is expected to propel the crocodile peptide market forward during the forecast period.
To Understand How Our Report Can Bring Difference to Your Business Strategy, Ask for a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=5006